Signaling and Regulation Activation of AndrogenReceptor , Lipogenesis , andOxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells

  2011cited by this paper
• Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells*

  2010cited by this paper
• Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression

  2010cited by this paper
• Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration‐resistant prostate cancer in a mouse xenograft model

  2010cited by this paper
• Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase

  2009cited by this paper
• Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.

  2009cited by this paper
• Oxidative stress in prostate cancer.

  2009cited by this paper
• Statins and prostate cancer prevention: where we are now, and future directions

  2008cited by this paper
• Saturated fat intake predicts biochemical failure after prostatectomy

  2008cited by this paper
• Cholesterol and Cholesterol-Rich Membranes in Prostate Cancer: An Update

  2008cited by this paper
• Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.

  2008cited by this paper
• Mechanisms of ROS modulated cell survival during carcinogenesis.

  2008cited by this paper
• β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells

  2008cited by this paper
• The ROS-NOX connection in cancer and angiogenesis.

  2008cited by this paper
• Phosphoinositide 3-Kinase-independent Non-genomic Signals Transit from the Androgen Receptor to Akt1 in Membrane Raft Microdomains*

  2007cited by this paper
• Increased lipogenesis in cancer cells: new players, novel targets

  2006cited by this paper
• β2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP–Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor Axis

  2006cited by this paper
• Evaluation on the phagocytosis of apoptotic spermatogenic cells by Sertoli cells in vitro through detecting lipid droplet formation by Oil Red O staining.

  2006cited by this paper
• cAMP-Dependent Protein Kinase A Signaling Pathway Osteomimicry of Prostate Cancer Cells : Role of Human Osteocalcin and Bone Sialoprotein Mediating

  2005cited by this paper
• Increased Nox1 and hydrogen peroxide in prostate cancer

  2005cited by this paper
• In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells

  2005cited by this paper
• Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer.

  2005cited by this paper
• The emerging role of the PI3-K-Akt pathway in prostate cancer progression

  2005cited by this paper
• Androgens, lipogenesis and prostate cancer.

  2004cited by this paper
• Fatty acid synthase: A metabolic oncogene in prostate cancer?

  2004cited by this paper
• Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence

  2004influential reference
• Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells.

  2003cited by this paper
• Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation

  2003cited by this paper
• Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.

  2003cited by this paper
• Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.

  2001cited by this paper
• Androgen receptor signaling in androgen-refractory prostate cancer.

  2001cited by this paper
• LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis

  2000cited by this paper
• Dietary fat and prostate cancer: current status.

  1999cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• Calcium‐dependence of hydrogen peroxide‐induced c‐fos expression and growth stimulation of multicellular prostate tumor spheroids

  1997cited by this paper
• Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defective cells.

  1996cited by this paper
• Two Tandem Binding Sites for Sterol Regulatory Element Binding Proteins Are Required for Sterol Regulation of Fatty-acid Synthase Promoter*

  1996cited by this paper
• P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

  1996cited by this paper
• Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide.

  1996cited by this paper
• Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene.

  1996cited by this paper
• Role of oxygen free radicals in cancer development.

  1996cited by this paper
• Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

  1994cited by this paper
• SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

  1994cited by this paper
• Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization.

  1993cited by this paper
• Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence.

  1993cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• Tumorigenesis and Neoplastic Progression Ezetimibe Is an Inhibitor of Tumor Angiogenesis

  year unknowncited by this paper

• No citing papers are available for this paper.